心包穿刺留置导管引流心包积液的临床疗效

目的评价心包穿刺留置导管引流治疗心包积液的临床疗效及安全性。方法45例心包积液患者在心尖部、剑突下穿刺心包，置入单腔中心静脉导管，反复抽液或注入治疗药物，观察患者液体的引流及临床情况。结果全部病例均安全置管引流，共引流放液132次，留置时间2～25d，14例病人从导管内注入抗结核和抗癌药物，临床症状明显改善。所有患者术中、术后未发生并发症。结论应用中心静脉导管穿刺心包，多次抽液，不仅减少反复穿刺给病人带来的不利影响，又降低了费用，此导管具有良好的生物相容性，特制的柔性软头对心肌、血管无损伤，经导管引流心包积液是安全、简便、易行的治疗方法。

Pericardiocentesis and Indwelling Central Venous Catheter Drainage of Pericardial Effusion: Clinical Efficacy

Objective To evaluate the clinical efficacy and safety of pericardiocentesis and indwelling central venous catheter drainage of pericardial effusion Methods Pericardiocentesis was carried out at the apex and subxiphoid and then a single-chamber central ve- nous catheter was inserted to pump liquid or inject drug repeatedly in 45 cases of pericardial effusion. The drainage of efflusion and clinical efficacy were observed. Results Pericardiocentesis and indwelling catheter drainage were successful in all cases. Pericardial effusion was drained 132 times totally and the indwelling time was from 2-25 days. Anti-tuberculosis and anti-cancer drugs were injected from the catheter in 14 cases. Clinical symptoms were improved significantly. No comphcation happened during or after the operation. Conclusion The method of pericardiocentesis and indwelling central venous catheter drain peficardial effusion repeatedly not only relieves the pain due to pericardial puncture repeatedly, but cuts down the cost well. The catheter has good biocompatibility, and its specially made soft end has no harm to the myocardium and blood vessel. Indwelling central venous catheter draining of pericardial effusion is safety and convenient.